White House reportedly eyeing restrictions to prescription drug advertising
Source: SeekingAlpha
2025-06-17 11:17:27 ET
More on AbbVie, Eli Lilly, etc.
- Eli Lilly: The Buy Case Gets Stronger (Rating Upgrade)
- AbbVie's Diversification Strategy Cushions Venetoclax MDS Blow
- Novo Nordisk: An Elite Company That Prints Money
- Lilly-Verve deal sends gene editing stocks higher
- Dividend stocks and ETFs draw attention as Middle East tensions continue
Read the full article on Seeking Alpha
For further details see:
White House reportedly eyeing restrictions to prescription drug advertising
Otsuka Holdings Co. Ltd.
NASDAQ: OTSKF
OTSKF Trading
0.0% G/L:
$68 Last:
210 Volume:
$68 Open:
OTSKF Latest News
May 17, 2025 01:00:00 am
Innovations in High Blood Pressure Intervention Benefit Patients with Resistant Hypertension
February 06, 2025 02:00:00 pm
TANAKA to Provide Medals for the Tokyo Marathon 2025 That Represent All the Participants in the Event with Woven Lines
